Article
Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target.
Viruses - 22 May 2020
Buhlig Timothy S, Bowersox Anastasia F, Braun Daniel L, Owsley Desiree N, James Kortney D, Aranda Alfredo J, Kendrick Connor D, Skalka Nicole A, Clark Daniel N
Abstract excerpt
Approximately 250 million people are living with chronic hepatitis B virus (HBV) infections, which claim nearly a million lives annually. The target of all current HBV drug therapies (except interferon) is the viral polymerase; specifically, the reverse transcriptase domain. Although no high-resolution structure exists for the HBV polymerase, several recent advances have helped to map its functions to specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
